Iodide

Iodide

SCHEMBL3086980

Cc1cc(NC(=O)CCN)no1.I

nearest known ligand 0.64

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.64
GAA P10253 2/20 0.64
EGFR P00533 1/20 0.64
MAPT P10636 2/20 0.60
PKM P14618 1/20 0.59
L3MBTL1 Q9Y468 2/20 0.58
NPC1 O15118 1/20 0.57
LMNA P02545 1/20 0.57
GAPDH P04406 2/20 0.56
HSD17B10 Q99714 2/20 0.56
MEN1 O00255 2/20 0.56
KMT2A Q03164 2/20 0.56
POLB P06746 1/20 0.56
HPGD P15428 1/20 0.56
ALOX15 P16050 1/20 0.56
APEX1 P27695 1/20 0.56
PTPN7 P35236 1/20 0.56
RECQL P46063 1/20 0.56
BLM P54132 1/20 0.56
BCL2L1 Q07817 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1302998 0.98 ALDH1A1 (0.66) ALDH1A1GAAEGFRMAPTPKM
Hydrochloric Acid SCHEMBL3086707 0.97 ALDH1A1 (0.64) ALDH1A1GAAEGFRMAPTPKM
SCHEMBL4112089 0.83 ALDH1A1 (0.68) ALDH1A1GAAEGFRMAPTPKM
SCHEMBL4858124 0.82 ALDH1A1 (0.66) ALDH1A1GAAEGFRMAPTPKM
SCHEMBL19987440 0.81 ALDH1A1 (0.64) ALDH1A1GAAEGFRMAPTPKM
SCHEMBL4110225 0.80 ALDH1A1 (0.72) ALDH1A1GAAEGFRMAPTL3MBTL1
SCHEMBL5849633 0.79 ALDH1A1 (0.67) ALDH1A1GAAEGFRMAPTPKM
SCHEMBL2639256 0.78 ALDH1A1 (0.70) ALDH1A1GAAEGFRMAPTPKM
SCHEMBL2639258 0.78 ALDH1A1 (0.70) ALDH1A1GAAEGFRMAPTPKM
SCHEMBL145381 0.78 ALDH1A1 (0.70) ALDH1A1GAAEGFRMAPTPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7799810-B2 Organic compounds NOVARTIS AG (CH) 2010-09-21 US disclosed
US-20100120865-A1 Organic compounds NOVARTIS AG (CH) 2010-05-13 US disclosed
EP-2035413-A2 THIAZOLYL UREA DERIVATIVES AS PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS Novartis AG (CH) 2009-03-18 EP disclosed
WO-2008000421-A2 THIAZOLYL UREA DERIVATIVES AS PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS NOVARTIS AG (CH) 2008-01-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100120865-A1 Organic compounds PIK3C3, PIK3R3, PIK3R4 ALDH1A1 3211/4885GAA 678/4885EGFR 745/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.